INDIANAPOLIS (December 12, 2018) — BioCrossroads announced today that after 14 years as president and CEO, David L. Johnson will leave the organization, effective December 31, 2018, to assume his responsibilities as president and CEO of the Central Indiana Corporate Partnership (CICP) on a full-time basis. In December 2012, Johnson was elected president and CEO of CICP and has led both organizations in shared capacities since that time.
Nora Doherty, currently senior vice president of BioCrossroads and managing director of the Indiana Seed Funds, has been named by the BioCrossroads Board of Directors to serve as interim president and CEO until a permanent president and CEO is selected through a national search process.
CICP, as the parent organization of six talent and industry sector initiatives including BioCrossroads, has grown from a team of 30 professionals to over 100 employees over the last five years, due in part to CICP’s development of two new branded initiatives, Ascend Indiana and AgriNovus Indiana. The other initiatives under the umbrella are Conexus Indiana, Energy Systems Network and TechPoint — all of which spearhead and implement projects to drive collaboration, innovation, investment and talent across Indiana’s advanced industries.
“It’s definitely the right time for this transition, but it’s still a bittersweet moment for me to leave the professional team and life sciences leaders who have energized every day of my professional life for more than 15 years, starting in 2002 when I served as one of the community volunteers launching BioCrossroads,” said David Johnson. “This organization has never been stronger, and the prospects for this premier economic sector have never been brighter—even though the stakes for future growth are always high. I look forward to what I know will be an even more successful next generation of BioCrossroads leadership and, in the interim, have great confidence in Nora Doherty’s considerable abilities to move BioCrossroads forward through a time of change.”
BioCrossroads is the oldest of the six CICP initiatives and has been nationally recognized as a model of collaboration and data driven efforts that support, enable, and build on Indiana’s already significant life sciences community.
“David Johnson’s influence on Indiana’s life sciences industry is beyond anything we could have hoped for at the onset of BioCrossroads,” said Darren Carroll, senior vice president – Corporate Business Development, Eli Lilly and Company and chairman of the BioCrossroads Board of Directors. “He has brilliantly led the organization, focusing efforts on collaboration, communication, capital, and talent. Just a couple of the many notable contributions include: raising nearly $400 million for Indiana’s life sciences opportunities, organizing and spearheading the Indiana Biosciences Research Institute and 16 Tech Innovation Community development, and forging unique collaborations that have ensured the sector’s statewide and national prominence.”
BioCrossroads has engaged a professional search firm, Odgers Berndtson, to manage the hiring process. Visit www.biocrossroads.com for more information.
BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region’s existing research and corporate strengths while encouraging new business development. BioCrossroads invests capital and provides support to life sciences businesses, launches new life sciences enterprises (Indiana Biosciences Research Institute, Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana’s life science institutions, promotes science education and markets Indiana’s life sciences industry.